Systemic Manifestations and Comorbidities of Chronic Obstructive Pulmonary Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Pulmonary Medicine

• Publication date

  2014-07-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1097/CPM.0000000000000044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study.

  2013cited by this paper
• Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity.

  2013cited by this paper
• Beta-blocker use and COPD mortality: a systematic review and meta-analysis

  2012cited by this paper
• Systemic manifestations of COPD.

  2012cited by this paper
• Anemia is a Mortality Predictor in Hospitalized Patients for COPD Exacerbation

  2012cited by this paper
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

  2012cited by this paper
• A Comprehensive Care Management Program to Prevent Chronic Obstructive Pulmonary Disease Hospitalizations

  2012cited by this paper
• Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease

  2012cited by this paper
• Association of Gastroesophageal Reflux Disease Symptoms with Stable Chronic Obstructive Pulmonary Disease

  2012cited by this paper
• Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype

  2012cited by this paper
• The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD.

  2012influential reference
• Comorbidities of chronic obstructive pulmonary disease

  2011cited by this paper
• Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study

  2011cited by this paper
• Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST)

  2011cited by this paper
• Pathogenic triad in COPD: oxidative stress, protease–antiprotease imbalance, and inflammation

  2011cited by this paper
• Poorly Treated or Unrecognized GERD Reduces Quality of Life in Patients with COPD

  2011cited by this paper
• Determinants of elevated healthcare utilization in patients with COPD

  2011cited by this paper
• Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort.

  2011cited by this paper
• Trends in cause-specific mortality in oxygen-dependent chronic obstructive pulmonary disease.

  2011cited by this paper
• Obstructive sleep apnea in chronic obstructive pulmonary disease patients

  2011cited by this paper
• Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians

  2011cited by this paper
• Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.

  2011cited by this paper
• Chronic obstructive pulmonary disease--an independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease.

  2010cited by this paper
• Increased risk of myocardial infarction and stroke following exacerbation of COPD.

  2010cited by this paper
• Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease

  2010cited by this paper
• Cognitive function in COPD

  2010cited by this paper
• Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.

  2010cited by this paper
• Susceptibility to exacerbation in chronic obstructive pulmonary disease.

  2010cited by this paper
• A meta-analysis of cytokines in major depression.

  2010cited by this paper
• Chronic obstructive pulmonary disease phenotypes: the future of COPD.

  2010cited by this paper
• Infection as a comorbidity of COPD

  2010cited by this paper
• American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

  2010cited by this paper
• Mortality in COPD: Causes, Risk Factors, and Prevention

  2010cited by this paper
• Abnormal swallowing reflex and COPD exacerbations.

  2010cited by this paper
• Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.

  2010cited by this paper
• Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial.

  2010cited by this paper
• Outpatient pulmonary rehabilitation following acute exacerbations of COPD

  2010cited by this paper
• Prevalence of multiple chronic conditions in the United States' Medicare population

  2009cited by this paper
• The six‐minute walk test: a useful metric for the cardiopulmonary patient

  2009cited by this paper
• CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD

  2009cited by this paper
• Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs.

  2009cited by this paper
• Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study

  2009cited by this paper
• Airflow limitation in smokers is associated with subclinical atherosclerosis.

  2009cited by this paper
• Development and first validation of the COPD Assessment Test

  2009cited by this paper
• COPD prevalence is increased in lung cancer, independent of age, sex and smoking history

  2009cited by this paper
• Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.

  2009cited by this paper
• The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease

  2009cited by this paper
• Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD.

  2009cited by this paper
• Pulmonary rehabilitation for management of chronic obstructive pulmonary disease.

  2009cited by this paper
• Is COPD really a cardiovascular disease?

  2009cited by this paper
• Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.

  2009cited by this paper
• Systemic manifestations and comorbidities of COPD

  2009influential reference
• Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD.

  2008cited by this paper
• Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation

  2008cited by this paper
• Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD

  2008cited by this paper
• Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction

  2008cited by this paper
• Pulmonary hypertension in COPD

  2008cited by this paper
• Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations.

  2008cited by this paper
• Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure.

  2008cited by this paper
• Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease.

  2008cited by this paper
• Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease.

  2008cited by this paper
• Methodological issues in therapeutic trials of COPD

  2008cited by this paper
• Prevalence of moderate and severe renal insufficiency in older persons with hypertension, diabetes mellitus, coronary artery disease, peripheral arterial disease, ischemic stroke, or congestive heart failure in an academic nursing home.

  2008cited by this paper
• Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

  2008cited by this paper
• Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.

  2008cited by this paper
• The metabolic syndrome, diabetes and lung dysfunction.

  2008cited by this paper
• Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease.

  2008cited by this paper
• Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD.

  2008cited by this paper
• Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines.

  2007cited by this paper
• Haemoglobin level and its clinical impact in a cohort of patients with COPD

  2007cited by this paper
• Systematic review of noninvasive positive pressure ventilation in severe stable COPD

  2007cited by this paper
• Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease.

  2007cited by this paper
• High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD.

  2007cited by this paper
• Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk

  2007cited by this paper
• Systemic inflammation and mortality in chronic obstructive pulmonary disease.

  2007cited by this paper
• Screening of Cognitive Impairment in Chronic Obstructive Pulmonary Disease

  2007cited by this paper
• Insulin Resistance and inflammation—A Further Systemic Complication of COPD

  2007cited by this paper
• Statin use reduces decline in lung function: VA Normative Aging Study.

  2007cited by this paper
• A practical screening tool for anxiety and depression in patients with chronic breathing disorders.

  2007cited by this paper
• Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?

  2007cited by this paper
• [COPD as a systemic disease].

  2007cited by this paper
• Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial

  2007cited by this paper
• Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity.

  2007cited by this paper
• Self-management strategies in chronic obstructive pulmonary disease.

  2007cited by this paper
• Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease.

  2007cited by this paper
• The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism.

  2007cited by this paper
• Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: Systematic review and meta-analysis.

  2007cited by this paper
• Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease.

  2007cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• Mortality risk factors in sleep apnoea: a matched case–control study

  2007cited by this paper
• Effects of nocturnal noninvasive mechanical ventilation on heart rate variability of patients with advanced COPD.

  2007cited by this paper
• Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.

  2007cited by this paper
• Potential therapeutic role for statins in respiratory disease

  2006cited by this paper
• Patterns of inflammation and the use of reversibility testing in smokers with airway complaints

  2006cited by this paper
• Role of gastroesophageal reflux symptoms in exacerbations of COPD.

  2006cited by this paper
• The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.

  2006cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study

  2006cited by this paper
• Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial

  2006cited by this paper
• Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases.

  2006cited by this paper
• Statin use is associated with reduced mortality in COPD

  2006cited by this paper

• Association of Vitamin D Levels in Chronic Obstructive Pulmonary Disease

  2025cites this paper
• The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis

  2017cites this paper